The Macular Disease Foundation Australia (MDFA)’s first-ever social impact survey has revealed a quarter of patients have low levels of knowledge of their condition, with roughly the same proportion less than happy with the explanation of their disease by their eyecare professional.
Eight Australian researchers are taking their projects to the next level with a share of more than $1 million in research funding from Macular Disease Foundation Australia (MDFA). Read more
Clinical trials for an eye test that can detect Alzheimer’s disease before it damages the brain could be under way in less than two years, according to world-first research led by Western Sydney University. Read more
Australia’s first clinical trials of an investigational gene therapy for dry age-related macular degeneration (AMD) has commenced at the Centre for Eye Research Australia (CERA). Read more
A new cataract surgery survey conducted through RANZCO has reaffirmed the gulf between the private and public systems, as well as a snapshot of surgeons’ perceptions of Snellen acuity and controversial simultaneous bilateral cataract procedures. Read more
A new study involving Moorfields Eye Hospital has found people who consume alcohol moderately have a lower chance of developing cataracts that require surgery, especially if they consume wine. Read more
Flinders University and the Queensland Eye Institute Foundation (QEIF) have formed a new partnership to create a world-first international registry for lymphoma in the eye. Read more
Melbourne researchers have identified an additional seven regions in the human genome that increase the risk of macular telangiectasia type 2 (MacTel), with one particular mutation raising the likelihood of the condition five-fold. Read more
Two Australian ophthalmologists are repurposing a common cholesterol-lowering drug into a topical ocular therapy for dry eye and blepharitis, which was given to a patient as part of an initial trial who went 90 seconds without blinking.
Nova Eye Medical has announced positive five-year follow-up data from a sub-study analysis of the multi-centre LEAD trial for its 2RT nano-pulse ophthalmic laser therapy. Read more